41 – 50 of 990
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Early Pharmacodynamic Changes Measured Using RNA Sequencing of Peripheral Blood from Patients in a Phase I Study with Mitazalimab, a Potent CD40 Agonistic Monoclonal Antibody
(
- Contribution to journal › Article
-
Mark
Nordic microalgae produce biostimulant for the germination of tomato and barley seeds
(
- Contribution to journal › Article
-
Mark
Targeted spatial proteomic analysis of CD8+ T- and myeloid cells in tonsillar cancer
(
- Contribution to journal › Article
-
Mark
ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1
(
- Contribution to journal › Article
-
Mark
Design, structure and plasma binding of ancestral β-CoV scaffold antigens
(
- Contribution to journal › Article
-
Mark
Exploring Spatial Heterogeneity of Immune Cells in Nasopharyngeal Cancer
(
- Contribution to journal › Article
-
Mark
Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high dose chemotherapy independent of MIPI and complement established high-risk factors
(
- Contribution to journal › Article
-
Mark
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry
(
- Contribution to journal › Article
-
Mark
Protective non-neutralizing mAbs Ab94 and Ab81 retain high-affinity and potent Fc-mediated function against SARS-CoV-2 variants from Omicron to XBB1.5
2023)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Exploring new prognostic biomarkers in Mantle Cell Lymphoma : a comparison of the circSCORE and the MCL35 score
(
- Contribution to journal › Article